Equities

Adimmune Corp

4142:TAI

Adimmune Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)22.35
  • Today's Change0.150 / 0.68%
  • Shares traded1.14m
  • 1 Year change-33.08%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,7852,2521,794
OPERATING EXPENSES
Cost of revenue total1,3741,3611,177
Selling, general and admin. expenses, total832446345
Depreciation/amortization5.005.174.94
Unusual expense(income)--04.39
Other operating expenses, total------
Total operating expense2,5082,1581,852
Operating income(723)94(58)
Other, net(8.59)1871
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(770)15614
Provision for income taxes010.000
Net income after taxes(770)14614
Minority interest13014529
Net income before extra. Items(640)29143
Total extraordinary items------
Net income(640)29143
Inc.avail. to common excl. extra. Items(640)29143
Inc.avail. to common incl. extra. Items(640)29143
EPS RECONCILIATION
Basic/primary weighted average shares422427430
Basic/primary eps excl. extra items(1.52)0.680.10
Basic/primary eps incl. extra items(1.52)0.680.10
Dilution adjustment--00
Diluted weighted average shares422428430
Diluted eps excl. extra items(1.52)0.680.10
Diluted eps incl. extra items(1.52)0.680.10
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental332315
SUPPLEMENTAL INCOME
Depreciation, supplemental199234201
Total special items0.04(0.01)4.38
NORMALISED INCOME
Normalized income before taxes(770)15619
Effect of special items on income taxes00.000
Income tax excluding impact of special items010.000
Normalized income after tax(770)14619
Normalized income avail. to common(640)29147
Basic normalized EPS(1.52)0.680.11
Diluted normalized EPS(1.52)0.680.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.